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Gillian A LancasterAbstract
This editorial introduces the new, online, open-access journal Pilot and Feasibility Studies. The journal considers
manuscripts on any aspect of the design and analysis of pilot and feasibility studies, as well as protocols for pilot
and feasibility studies, and discussions and reviews of methodological issues around the planning and reporting
of such studies. These studies are generally carried out in preparation for future large-scale definitive randomised
controlled trials or observational studies and address key issues of uncertainty. Objectives for conducting pilot
and feasibility studies therefore differ from those of the future large-scale study and should be clearly expressed.
The journal provides a dedicated place for publication of this important work as well as a forum for discussion of
methodological issues that will lead to increased scientific rigour in this area.Introduction
Welcome to this first edition of a new journal called
Pilot and Feasibility Studies. This is an exciting addition
to the BioMed Central portfolio of journals and is long
overdue. The journal is online and open-access ensuring
that it is available to researchers from all over the world.
Moreover, because of its multi-disciplinary nature, re-
searchers will benefit from seeing a range of pilot and
feasibility studies reported from across many subject areas,
facilitating the sharing of ideas. There will be a strong
focus on pilot and feasibility studies that are in preparation
for a randomised controlled trial, the gold standard of
study designs, but this is by no means exclusive to other
types of studies, and certainly similar preparation should
take place for observational study designs, too. The key
issue here is uncertainty and how that is to be addressed
when focusing upon planning a future large-scale study.
Previously, many pilot and feasibility studies have
remained unpublished, and yet this work is crucial to
the success of a future trial. It is encouraging that pilot
trials are now being registered within National Trials
registries to improve transparency and accountability, not
least to funders [1]. Trial registration is also a condition
for publication in the BioMed Central sister journal Trials
[2]. There is however still a way to go in the reporting of
other types of pilot and feasibility studies, although more
are being registered on the UK Clinical Research Network
Portfolio Database (http://public.ukcrn.org.uk). These areCorrespondence: g.lancaster@lancaster.ac.uk
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unless otherwise stated.of equal importance in ensuring that all processes work
and run smoothly, that interventions are safe and have
shown efficacy, and may include qualitative work that helps
us to more easily understand and appreciate patients’ and
health professionals’ perspectives [3], and cost effectiveness
modelling [4]. Pilot and Feasibility Studies provides a
ready forum for discussion around these key aspects of
the scientific process, sharing knowledge in the planning
of large-scale clinical investigations and so completing the
publication cycle for clinical and health research.
The aim of this journal is to provide a dedicated place
for the reporting of feasibility and pilot studies, and discus-
sion of methodological issues around the planning, of
future large-scale definitive trials and observational stud-
ies. Articles may include randomised pilot trials, non-
randomised feasibility and pilot studies, methodological
discussion and review papers, protocols for pilot and feasi-
bility studies, qualitative work in preparation for a large-
scale study, phase II studies that address preparatory work
for a future trial, proof-of-concept studies, Vanguard
studies and similar related studies not covered within
the above terminology. The main focus of the above is
on external stand-alone pilot and feasibility studies. How-
ever, with more attention being placed on adaptive trial
designs and internal pilot studies, then submissions on in-
ternal pilot studies that address interesting preparatory
work and/or innovative adaption are also encouraged.is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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feasibility studies
The Medical Research Council (MRC) and National
Institute for Health Research (NIHR) have both published
guidelines for conducting pilot and feasibility studies. The
MRC guidelines on complex interventions present the
view that pilot and feasibility testing are interchange-
able concepts covering all aspects of preparatory work
[5] (see www.mrc.ac.uk/complexinterventionsguidance):
‘Questions to ask yourself include: Have you done
enough piloting and feasibility work to be confident
that the intervention can be delivered as intended?
Can you make safe assumptions about effect sizes and
variability, and rates of recruitment and retention in
the main evaluation study? What design are you going
to use, and why? Is an experimental design preferable
and if so, is it feasible?’
In the NIHR online glossary feasibility studies and pilot
studies are described in two separate entries. There are ex-
amples of feasibility parameters that may need to be tested
in preparation for the main trial, and there is a suggestion
that this process might come before more substantial pilot
work (see ‘Feasibility studies’ and ‘Pilot studies’ entries at
http://www.nets.nihr.ac.uk/glossary):
‘Pilot studies are a smaller version of the main study
used to test whether the components of the main
study can all work together. It is focused on the
processes of the main study, for example to ensure
that recruitment, randomisation, treatment, and
follow-up assessments all run smoothly.’
Useful guidelines for conducting pilot and feasibility
studies have also been published in other subject-specific
areas, including occupational therapy [6], critical care [7],
perinatal and neonatal nursing [8], nursing science [9],
psychiatry [10] and social research [11]. However, there
exists little guidance on how to report pilot and feasibility
studies.
In 2012, a consortium of six people (see the
‘Acknowledgements’ section), including myself, set out to
develop new Consolidated Standards of Reporting Trials
(CONSORT) extension guidelines for reporting pilot and
feasibility studies. The original CONSORT guidelines were
most recently updated in 2010 and focus on the report-
ing of randomised controlled trials [12]. Extensions to
these guidelines, for example, to cluster randomised trials
[13] and pragmatic trials [14] have since been developed.
We had previously published articles on the conduct of
pilot and feasibility studies and presented conference
workshops on the subject, which highlighted a clear
need for such guidelines. Since then, a comprehensivebody of work has been carried out, which has included
consulting experts in the field, journal editors and funders.
Our work has resulted in a set of reporting guidelines for
pilot trials, which is currently being written up, and in fact
the creation of this journal is a very positive indication of
publisher support for this work.
As well as developing the new CONSORT extension
guidelines for pilot and feasibility trials, consideration has
also been given to the construction of definitions as to
what constitutes a ‘feasibility study’ and ‘pilot study’, which
has given rise to much interesting debate. To date, our
work has shown that there is a lack of consensus over the
different usage of the words ‘pilot’ and ‘feasibility’ in this
context. Consequently, both terms are currently being
used interchangeably in this journal. Our work is soon to
be published and this will hopefully open up new avenues
of debate around terminology.Key objectives of pilot and feasibility studies
A major issue of concern in previously published work
has been around appropriate objectives for conducting
a pilot or feasibility study. These objectives should be
different from those of the future definitive study and
should stipulate the issues of uncertainty to be addressed
in preparation for the future large-scale study. Moreover,
pilot and feasibility studies are not designed (or powered)
to address the effectiveness of the intervention. This is an
objective of the future definitive trial. Nevertheless, these
are issues that often arise in publications and lead to con-
fusion of the reasons for a pilot or feasibility study.
In 2004, Lancaster et al. [15] published recommenda-
tions for good practice in relation to the design of pilot
and feasibility studies, and highlighted seven evidence-
based key objectives found in their literature review of
pilot and feasibility papers published in 2000/2001. These
are (i) to test the integrity of the study protocol for the fu-
ture trial (which gives a valid reason for randomisation)
and (ii) to gain initial estimates for sample size calculation,
and it is helpful to note here recent work in this area
[16,17] (iii) to test data collection forms or questionnaires,
(iv) to test randomisation procedure(s), (v) to estimate
rates of recruitment and consent, (vi) to determine the ac-
ceptability of the intervention and (vii) to select the most
appropriate primary outcome measure(s). This paper was
written to encourage researchers to carry out pilot and
feasibility studies for the right reasons and to deter them
from conducting mini-randomised controlled trials that
mirrored the main trial in all respects, except that they
were carried out on smaller numbers of participants. One
reason for this might be, for example, because it was easier
to conduct the study in a single centre rather than carry-
ing it out more appropriately across multiple centres to in-
crease sample size.
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randomised trials and complex interventions, resulting
from talks given at the Royal Statistical Society Primary
Health Care Study Group meetings over a 10-year period,
highlights other key objectives [18]. In the same year,
Thabane et al. published a tutorial on pilot studies [19].
They also agreed that there were often no clear criteria
regarding feasibility objectives in proposals seen in their
work with research ethics boards. They further recom-
mended when possible formulating a priori ‘criteria for
success’ in interpreting the results of pilot and feasibil-
ity studies, for example, percentage achievement of re-
cruitment targets or acceptability objectives, and put
forward a checklist of items for reporting results based
on CONSORT.
A second related issue is the appropriate statistical ana-
lysis of pilot and feasibility studies, and whether the use of
hypothesis tests is acceptable in small under-powered
studies. McGrath [8] puts it this way:
‘Pilot studies because they are often underpowered
(small sample sizes) can only be used to generate
beliefs that there will be a trend toward significance
that provide support for larger studies. If significance
is found in a pilot study, one must still be prepared
that a full-scale trial could generate different results.’
Lancaster et al. [15] called for more emphasis to be
placed on confidence interval estimation rather than hy-
pothesis testing as then the imprecision of the estimates
can be clearly seen. Arain et al. [20] repeated the search
carried out by Lancaster et al. in 2001/2002 [15] for the
years 2007/2008 to see if current practice had changed.
They found that the majority (81%) of the 54 pilot and
feasibility studies identified from their search still incor-
porated hypothesis testing and some included tests of
treatment effectiveness. Nevertheless, this is evidence that
many journals continue to condone hypothesis testing in
small pilot or feasibility studies. Given that this practice is
unlikely to change in the near future, then we would stipu-
late that the emphasis given to hypothesis testing should
be treated as secondary and the results treated with
caution. This is in line with the recommendations of
Thabane et al. [19].
Whether or not hypothesis testing is to be used, what
is clear is that the main objective of a pilot or feasibility
study is not to test treatment effectiveness [10,15,19].
This is the objective of the future definitive trial. There-
fore, any preliminary testing should be clearly labelled as
such and issues of concern pointed out in the discussion
section of a paper. However, it is understood that there
may be instances when the collection of patient-related
outcome data might serve a useful purpose in future plan-
ning. However, this would not generally be the primaryfocus of a pilot or feasibility study, as the main objective(s)
should be concerned with addressing aspects of feasibility
and uncertainty.
A third issue related to the reporting of pilot and feasi-
bility studies is that it is important to state in the final
conclusions whether the aims and objectives of the pilot
or feasibility work have been met and are going to lead
on to a future large-scale study. In a recent review by
Shanyinde et al. [21], coverage of feasibility issues in the
discussion section of a paper was classified as ‘none’ or
‘minimal’ in 17/28 drug-related pilot trials and in 5/22
non-drug pilot trials, and the extent of discussion about
planning future trials was classified as ‘none’ or ‘minimal’
in 27/28 of the pilot drug trials and 14/22 non-drug trials.
This highlights that this important issue is not given
enough consideration. In many cases, the intension for
further work is left far too vague and this has been illus-
trated by other authors [15,19,20]. Bugge et al. [22] have
put forward a process for decision-making after pilot and
feasibility trials (ADePT). It can be used to classify and
analyse problems arising from the feasibility study as an
aid to identifying appropriate solutions, and they provide a
detailed example related to pelvic organ prolapse.
Several authors also warn against the pitfalls of includ-
ing the same pilot study participants in the main study
when external stand-alone pilot studies are carried out.
They highlight in this respect that the main study may
suffer from contamination of the study sample because
of modification to study methods after the pilot study
has completed [10], or because of previous exposure to
the intervention, or because of selection bias caused by
unrepresentative pilot sampling [11], for example, where
participants are recruited opportunistically and may not
truly reflect the target population of interest in the future
large-scale study. Charlesworth et al. [23] have proposed a
checklist for deciding whether pilot trial data can be car-
ried forward to the main trial without compromising trial
integrity, including consideration of acceptable permissible
changes to procedures between the pilot and main trial.
This may also prove helpful for use with adaptive trial
designs.
Conclusion
In conclusion, piloting new interventions for use in
definitive randomised controlled trials or testing the
feasibility of other aspects of uncertainty arising in the
development of large-scale studies ensures that the
methodological approach taken in the main study is
robust and feasible. These are important parts of the
development process and provide evidence to funders
that the future main trial will work. Pilot and feasibility
studies encompass all aspects of the design process, and
whilst this work is crucial to the success of a future trial,
in the past, such studies have seldom reached publication
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dedicated to supporting this type of work is long overdue.
It will enable researchers to learn from each other, discuss
and review previous approaches and share more easily
ideas for best scientific practice across subject areas.
We invite you to submit your papers to Pilot and
Feasibility Studies and to contribute to a new era in the
publication of such work, as pilot and feasibility studies
come of age!
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